SRTAW
Strata Critical Medical, Inc.
Price Chart
Latest Quote
$0.00
-0.00 (-88.68%)
Current Price
| Previous Close | $0.01 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 638,916 |
Stock Information
| Total Debt | $4.47M |
| Cash Equivalents | $58.79M |
| Revenue | $228.58M |
| Net Income | $-16.05M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $228.58M |
| Income | $-16.05M |
| Book/sh | $4.18 |
| Employees | 327 |
Financial Ratios
| Quick Ratio | 4.70 |
| Current Ratio | 5.93 |
| Debt/Eq | 1.56 |
Returns & Margins
| ROA | -1.95% |
| ROE | -6.35% |
| Gross Margin | 21.08% |
| Operating Margin | -2.52% |
| Profit Margin | 20.56% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.04 |
| SMA50 | $0.03 |
| RSI | nan |
| Shares Float | 61.70M |
| Volatility | 2.15 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| YTD | -12.50% |
| 10 Years | -12.50% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-05-18 | $0.04 | 0 |
| 2026-05-15 | $0.04 | 0 |
| 2026-05-14 | $0.04 | 0 |
| 2026-05-13 | $0.04 | 0 |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
đ° Latest News
How The Story Is Shifting For Strata Critical Medical (SRTA) After New Analyst Assumptions
Simply Wall St. âĸ 2026-05-25T00:16:02Z
Strata Critical Medical, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Simply Wall St. âĸ 2026-05-08T14:07:46Z
Strata Critical Medical, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T17:06:57Z
Strata (SRTA) Q1 2026 Earnings Call Transcript
Motley Fool âĸ 2026-05-06T16:22:08Z
How The Story Is Shifting For Strata Critical Medical (SRTA) After The Lower Fair Value Target
Simply Wall St. âĸ 2026-04-21T20:03:50Z
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration
Simply Wall St. âĸ 2026-04-15T18:05:23Z
Cathie Woodâs Ark keeps selling one stock once again
TheStreet âĸ 2026-04-15T11:03:00Z
Cathie Wood Dumps $10 Million of Mega Chip Stock
GuruFocus.com âĸ 2026-04-13T12:04:27ZStrata Critical Medical, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-04T13:30:00Z
Strata Critical Medical (SRTA) Earnings Call
Motley Fool âĸ 2026-03-03T14:19:05Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $150,434,000 | $112,524,000 | $183,058,000 | $123,845,000 |
| Cost Of Revenue | $156,015,000 | $117,228,000 | $183,058,000 | $123,845,000 |
| Total Revenue | $197,141,000 | $146,817,000 | $225,180,000 | $146,120,000 |
| Operating Revenue | $197,141,000 | $146,817,000 | $225,180,000 | $146,120,000 |
| Expenses | ||||
| Total Expenses | $219,494,000 | $169,342,000 | $293,297,000 | $199,649,000 |
| Other Income Expense | $-1,954,000 | $-850,000 | $2,133,000 | $22,063,000 |
| Net Non Operating Interest Income Expense | $4,241,000 | $7,214,000 | $8,442,000 | $3,434,000 |
| Operating Expense | $63,479,000 | $52,114,000 | $110,239,000 | $75,804,000 |
| Selling And Marketing Expense | - | $7,950,000 | $10,438,000 | $7,749,000 |
| General And Administrative Expense | - | $81,711,000 | $95,174,000 | $62,510,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-20,066,000 | $-16,161,000 | $-56,076,000 | $-27,260,000 |
| Net Interest Income | $4,241,000 | $7,214,000 | $8,442,000 | $3,434,000 |
| Interest Income | $4,241,000 | $7,214,000 | $8,442,000 | $3,434,000 |
| Normalized Income | $-18,112,000 | $-15,311,000 | $-58,154,608 | $-48,716,268 |
| Net Income From Continuing And Discontinued Operation | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Total Operating Income As Reported | $-22,353,000 | $-22,525,000 | $-68,117,000 | $-53,529,000 |
| Net Income Common Stockholders | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Net Income | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Net Income Including Noncontrolling Interests | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Net Income Discontinuous Operations | $61,413,000 | $-11,146,000 | - | - |
| Net Income Continuous Operations | $-20,066,000 | $-16,161,000 | $-56,076,000 | $-27,260,000 |
| Pretax Income | $-20,066,000 | $-16,161,000 | $-57,542,000 | $-28,032,000 |
| Interest Income Non Operating | $4,241,000 | $7,214,000 | $8,442,000 | $3,434,000 |
| Operating Income | $-22,353,000 | $-22,525,000 | $-68,117,000 | $-53,529,000 |
| Depreciation Amortization Depletion Income Statement | $2,604,000 | $1,258,000 | - | - |
| Depreciation And Amortization In Income Statement | $2,604,000 | $1,258,000 | - | - |
| Amortization Of Intangibles Income Statement | $2,604,000 | $1,258,000 | - | - |
| Gross Profit | $41,126,000 | $29,589,000 | $42,122,000 | $22,275,000 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $54,392 | $606,732 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,214,000 | $-15,713,000 | $-63,139,000 | $-69,867,000 |
| Total Unusual Items | $-1,954,000 | $-850,000 | $2,133,000 | $22,063,000 |
| Total Unusual Items Excluding Goodwill | $-1,954,000 | $-850,000 | $2,133,000 | $22,063,000 |
| Reconciled Depreciation | $8,185,000 | $5,962,000 | $7,111,000 | $5,725,000 |
| EBITDA (Bullshit earnings) | $-14,168,000 | $-16,563,000 | $-61,006,000 | $-47,804,000 |
| EBIT | $-22,353,000 | $-22,525,000 | $-68,117,000 | $-53,529,000 |
| Diluted NI Availto Com Stockholders | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Tax Provision | $0 | $0 | $-1,466,000 | $-772,000 |
| Gain On Sale Of Security | $-1,954,000 | $-850,000 | $2,133,000 | $22,063,000 |
| Amortization | $2,604,000 | $1,258,000 | - | - |
| Selling General And Administration | $60,875,000 | $50,856,000 | $105,612,000 | $70,259,000 |
| Research And Development | - | $3,184,000 | $4,627,000 | $5,545,000 |
| Other Gand A | - | $81,711,000 | $95,174,000 | $62,510,000 |
Fetched: 2026-04-30
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $143,360,000 | $198,434,000 | $173,408,000 | $188,679,000 |
| Total Assets | $325,472,000 | $256,675,000 | $294,938,000 | $325,025,000 |
| Total Non Current Assets | $199,280,000 | $95,933,000 | $88,677,000 | $106,899,000 |
| Other Non Current Assets | $24,017,000 | $41,133,000 | $1,402,000 | $1,360,000 |
| Goodwill And Other Intangible Assets | $135,712,000 | $23,504,000 | $60,892,000 | $85,810,000 |
| Other Intangible Assets | $47,502,000 | $7,964,000 | $20,519,000 | $46,365,000 |
| Current Assets | $126,192,000 | $160,742,000 | $206,261,000 | $218,126,000 |
| Other Current Assets | $24,739,000 | $4,676,000 | $17,971,000 | $12,086,000 |
| Assets Held For Sale Current | $0 | $11,152,000 | - | - |
| Restricted Cash | $264,000 | $263,000 | $1,148,000 | $3,085,000 |
| Receivables | $39,958,000 | $19,822,000 | $21,005,000 | $10,877,000 |
| Accounts Receivable | $39,958,000 | $19,822,000 | $21,005,000 | $10,877,000 |
| Allowance For Doubtful Accounts Receivable | $-1,066,000 | $0 | $-98,000 | $0 |
| Gross Accounts Receivable | $41,024,000 | $19,822,000 | $21,103,000 | $10,877,000 |
| Cash Cash Equivalents And Short Term Investments | $61,231,000 | $124,829,000 | $166,137,000 | $192,078,000 |
| Cash And Cash Equivalents | $30,968,000 | $16,072,000 | $27,873,000 | $41,338,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $3,307,000 | $3,018,000 | $24,525,000 | $18,332,000 |
| Long Term Debt And Capital Lease Obligation | $2,655,000 | $2,336,000 | $19,738,000 | $14,970,000 |
| Current Debt And Capital Lease Obligation | $652,000 | $682,000 | $4,787,000 | $3,362,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $46,400,000 | $34,737,000 | $60,638,000 | $50,536,000 |
| Total Non Current Liabilities Net Minority Interest | $26,606,000 | $12,011,000 | $25,147,000 | $23,929,000 |
| Other Non Current Liabilities | $22,073,000 | - | - | - |
| Liabilities Heldfor Sale Non Current | $0 | $3,867,000 | - | - |
| Derivative Product Liabilities | $1,530,000 | $5,808,000 | $4,958,000 | $7,083,000 |
| Non Current Deferred Liabilities | $348,000 | $0 | $451,000 | $1,876,000 |
| Non Current Deferred Taxes Liabilities | $348,000 | $0 | $451,000 | $1,876,000 |
| Current Liabilities | $19,794,000 | $22,726,000 | $35,491,000 | $26,607,000 |
| Payables And Accrued Expenses | $19,142,000 | $9,220,000 | $23,859,000 | $16,536,000 |
| Other Current Liabilities | - | $12,824,000 | - | - |
| Current Deferred Liabilities | - | $6,656,000 | $6,845,000 | $6,709,000 |
| Current Notes Payable | - | - | - | - |
| Payables | - | - | - | - |
| Accounts Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $279,072,000 | $221,938,000 | $234,300,000 | $274,489,000 |
| Total Equity Gross Minority Interest | $279,072,000 | $221,938,000 | $234,300,000 | $274,489,000 |
| Stockholders Equity | $279,072,000 | $221,938,000 | $234,300,000 | $274,489,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $1,753,000 | $3,964,000 | $2,287,000 |
| Retained Earnings | $-145,551,000 | $-186,898,000 | $-159,754,000 | $-103,678,000 |
| Other Equity Adjustments | - | $1,753,000 | $3,964,000 | $2,287,000 |
| Long Term Equity Investment | - | - | - | $390,000 |
| Other | ||||
| Ordinary Shares Number | $86,702,183 | $79,419,028 | $75,131,425 | $71,660,617 |
| Share Issued | $86,702,183 | $79,419,028 | $75,131,425 | $71,660,617 |
| Tangible Book Value | $143,360,000 | $198,434,000 | $173,408,000 | $188,679,000 |
| Invested Capital | $279,072,000 | $221,938,000 | $234,300,000 | $274,489,000 |
| Working Capital | $106,398,000 | $138,016,000 | $170,770,000 | $191,519,000 |
| Capital Lease Obligations | $3,307,000 | $3,018,000 | $24,525,000 | $18,332,000 |
| Total Capitalization | $279,072,000 | $221,938,000 | $234,300,000 | $274,489,000 |
| Additional Paid In Capital | $424,616,000 | $407,076,000 | $390,083,000 | $375,873,000 |
| Capital Stock | $7,000 | $7,000 | $7,000 | $7,000 |
| Common Stock | $7,000 | $7,000 | $7,000 | $7,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $2,655,000 | $2,336,000 | $19,738,000 | $14,970,000 |
| Current Capital Lease Obligation | $652,000 | $682,000 | $4,787,000 | $3,362,000 |
| Goodwill | $88,210,000 | $15,540,000 | $40,373,000 | $39,445,000 |
| Net PPE | $39,551,000 | $31,296,000 | $26,383,000 | $19,729,000 |
| Accumulated Depreciation | $-6,286,000 | $-2,574,000 | $-3,155,000 | $-2,234,000 |
| Gross PPE | $45,837,000 | $33,870,000 | $29,538,000 | $21,963,000 |
| Leases | $835,000 | $734,000 | $3,016,000 | $2,799,000 |
| Other Properties | $3,171,000 | $2,881,000 | $23,886,000 | $18,022,000 |
| Machinery Furniture Equipment | $5,299,000 | $401,000 | $886,000 | $407,000 |
| Other Short Term Investments | $30,263,000 | $108,757,000 | $138,264,000 | $150,740,000 |
| Current Deferred Revenue | - | $6,656,000 | $6,845,000 | $6,709,000 |
| Investments And Advances | - | - | - | $390,000 |
| Investmentsin Joint Venturesat Cost | - | - | - | $390,000 |
Fetched: 2026-04-30
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-59,924,000 | $-35,500,000 | $-34,458,000 | $-37,860,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-48,914,000 | $-2,519,000 | $-32,349,000 | $-37,130,000 |
| Cash Flow From Continuing Operating Activities | $-48,914,000 | $-2,519,000 | $-32,349,000 | $-37,130,000 |
| Operating Gains Losses | $-56,877,000 | $850,000 | $-2,125,000 | $-21,989,000 |
| Investing Activities | ||||
| Capital Expenditure | $-11,010,000 | $-32,981,000 | $-2,109,000 | $-730,000 |
| Investing Cash Flow | $69,750,000 | $-1,016,000 | $17,089,000 | $79,340,000 |
| Cash Flow From Continuing Investing Activities | $69,750,000 | $-1,016,000 | $17,089,000 | $79,340,000 |
| Capital Expenditure Reported | $-1,415,000 | $-2,119,000 | $0 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-244,000 | $0 | - |
| Financing Cash Flow | $-8,912,000 | $-5,759,000 | $-76,000 | $-1,084,000 |
| Cash Flow From Continuing Financing Activities | $-8,912,000 | $-5,759,000 | $-76,000 | $-1,084,000 |
| Net Other Financing Charges | $-9,105,000 | $-5,683,000 | $-146,000 | $-1,171,000 |
| Net Common Stock Issuance | $0 | $-244,000 | $0 | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $87,000 | $0 | $16,000 | $0 |
| End Cash Position | $31,232,000 | $19,647,000 | $29,021,000 | $44,423,000 |
| Beginning Cash Position | $19,647,000 | $29,021,000 | $44,423,000 | $3,225,000 |
| Effect Of Exchange Rate Changes | $-339,000 | $-80,000 | $-66,000 | $72,000 |
| Changes In Cash | $11,924,000 | $-9,294,000 | $-15,336,000 | $41,126,000 |
| Proceeds From Stock Option Exercised | $193,000 | $168,000 | $70,000 | $87,000 |
| Common Stock Payments | $0 | $-244,000 | $0 | - |
| Net Investment Purchase And Sale | $150,105,000 | $34,195,000 | $19,099,000 | $128,361,000 |
| Sale Of Investment | $296,363,000 | $177,450,000 | $285,069,000 | $356,377,000 |
| Purchase Of Investment | $-146,258,000 | $-143,255,000 | $-265,970,000 | $-228,016,000 |
| Net Business Purchase And Sale | $-69,345,000 | $-2,230,000 | $-39,000 | $-48,291,000 |
| Purchase Of Business | $-69,345,000 | $-2,230,000 | $-39,000 | $-48,291,000 |
| Net PPE Purchase And Sale | $-9,595,000 | $-30,862,000 | $-1,971,000 | $-730,000 |
| Purchase Of PPE | $-9,595,000 | $-30,862,000 | $-2,109,000 | $-730,000 |
| Change In Working Capital | $-9,080,000 | $-3,009,000 | $-6,737,000 | $-17,000 |
| Change In Other Working Capital | $1,596,000 | $45,000 | $496,000 | $1,348,000 |
| Change In Other Current Assets | $666,000 | $-70,000 | $4,000 | $-663,000 |
| Change In Payables And Accrued Expense | $2,378,000 | $-8,338,000 | $9,049,000 | $9,900,000 |
| Change In Prepaid Assets | $-1,686,000 | $6,352,000 | $-6,032,000 | $-5,255,000 |
| Change In Receivables | $-12,034,000 | $-998,000 | $-10,254,000 | $-5,347,000 |
| Changes In Account Receivables | $-12,034,000 | $-998,000 | $-10,254,000 | $-5,347,000 |
| Other Non Cash Items | $-52,426,000 | $-4,412,000 | $-6,473,000 | $-1,094,000 |
| Stock Based Compensation | $17,832,000 | $19,893,000 | $12,501,000 | $8,277,000 |
| Asset Impairment Charge | $1,673,000 | $5,759,000 | $20,916,000 | $0 |
| Deferred Tax | $432,000 | $-255,000 | $-1,466,000 | $-772,000 |
| Deferred Income Tax | $432,000 | $-255,000 | $-1,466,000 | $-772,000 |
| Depreciation Amortization Depletion | $8,185,000 | $5,962,000 | $7,111,000 | $5,725,000 |
| Depreciation And Amortization | $8,185,000 | $5,962,000 | $7,111,000 | $5,725,000 |
| Gain Loss On Investment Securities | $917,000 | $850,000 | $-2,125,000 | $-22,063,000 |
| Net Foreign Currency Exchange Gain Loss | $-798,000 | $0 | $6,000 | $6,000 |
| Gain Loss On Sale Of Business | $-56,996,000 | $0 | - | - |
| Net Income From Continuing Operations | $41,347,000 | $-27,307,000 | $-56,076,000 | $-27,260,000 |
| Sale Of PPE | - | $13,000 | $138,000 | $0 |
| Amortization Cash Flow | - | $2,986,000 | $6,036,000 | - |
| Amortization Of Intangibles | - | $2,986,000 | $6,036,000 | - |
| Depreciation | - | $2,976,000 | $1,075,000 | - |
| Gain Loss On Sale Of PPE | - | - | $48,000 | $68,000 |
| Repayment Of Debt | - | - | - | $0 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-04-30